Cargando…

Real-world evidence in achondroplasia: considerations for a standardized data set

BACKGROUND: Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanay, Yasemin, Mohnike, Klaus, Nilsson, Ola, Alves, Inês, AlSayed, Moeenaldeen, Appelman-Dijkstra, Natasha M., Baujat, Genevieve, Ben-Omran, Tawfeg, Breyer, Sandra, Cormier-Daire, Valerie, Gregersen, Pernille Axél, Guillén-Navarro, Encarna, Högler, Wolfgang, Maghnie, Mohamad, Mukherjee, Swati, Cohen, Shelda, Pimenta, Jeanne, Selicorni, Angelo, Semler, J. Oliver, Sigaudy, Sabine, Popkov, Dmitry, Sabir, Ian, Noval, Susana, Sessa, Marco, Irving, Melita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294372/
https://www.ncbi.nlm.nih.gov/pubmed/37365619
http://dx.doi.org/10.1186/s13023-023-02755-w
_version_ 1785063181863878656
author Alanay, Yasemin
Mohnike, Klaus
Nilsson, Ola
Alves, Inês
AlSayed, Moeenaldeen
Appelman-Dijkstra, Natasha M.
Baujat, Genevieve
Ben-Omran, Tawfeg
Breyer, Sandra
Cormier-Daire, Valerie
Gregersen, Pernille Axél
Guillén-Navarro, Encarna
Högler, Wolfgang
Maghnie, Mohamad
Mukherjee, Swati
Cohen, Shelda
Pimenta, Jeanne
Selicorni, Angelo
Semler, J. Oliver
Sigaudy, Sabine
Popkov, Dmitry
Sabir, Ian
Noval, Susana
Sessa, Marco
Irving, Melita
author_facet Alanay, Yasemin
Mohnike, Klaus
Nilsson, Ola
Alves, Inês
AlSayed, Moeenaldeen
Appelman-Dijkstra, Natasha M.
Baujat, Genevieve
Ben-Omran, Tawfeg
Breyer, Sandra
Cormier-Daire, Valerie
Gregersen, Pernille Axél
Guillén-Navarro, Encarna
Högler, Wolfgang
Maghnie, Mohamad
Mukherjee, Swati
Cohen, Shelda
Pimenta, Jeanne
Selicorni, Angelo
Semler, J. Oliver
Sigaudy, Sabine
Popkov, Dmitry
Sabir, Ian
Noval, Susana
Sessa, Marco
Irving, Melita
author_sort Alanay, Yasemin
collection PubMed
description BACKGROUND: Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, would improve understanding of the natural history of achondroplasia, quality of life, and related outcomes. METHODS: The Europe, Middle East, and Africa (EMEA) Achondroplasia Steering Committee comprises a multidisciplinary team of 17 clinical experts and 3 advocacy organization representatives. The committee undertook an exercise to identify essential data elements for a standardized prospective registry to study the natural history of achondroplasia and related outcomes. RESULTS: A range of RWE on achondroplasia is being collected at EMEA centres. Whereas commonalities exist, the data elements, methods used to collect and store them, and frequency of collection vary. The topics considered most important for collection were auxological measures, sleep studies, quality of life, and neurological manifestations. Data considered essential for a prospective registry were grouped into six categories: demographics; diagnosis and patient measurements; medical issues; investigations and surgical events; medications; and outcomes possibly associated with achondroplasia treatments. CONCLUSIONS: Long-term, high-quality data are needed for this rare, multifaceted condition. Establishing registries that collect predefined data elements across age spans will provide contemporaneous prospective and longitudinal information and will be useful to improve clinical decision-making and management. It should be feasible to collect a minimum dataset with the flexibility to include country-specific criteria and pool data across countries to examine clinical outcomes associated with achondroplasia and different therapeutic approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02755-w.
format Online
Article
Text
id pubmed-10294372
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102943722023-06-28 Real-world evidence in achondroplasia: considerations for a standardized data set Alanay, Yasemin Mohnike, Klaus Nilsson, Ola Alves, Inês AlSayed, Moeenaldeen Appelman-Dijkstra, Natasha M. Baujat, Genevieve Ben-Omran, Tawfeg Breyer, Sandra Cormier-Daire, Valerie Gregersen, Pernille Axél Guillén-Navarro, Encarna Högler, Wolfgang Maghnie, Mohamad Mukherjee, Swati Cohen, Shelda Pimenta, Jeanne Selicorni, Angelo Semler, J. Oliver Sigaudy, Sabine Popkov, Dmitry Sabir, Ian Noval, Susana Sessa, Marco Irving, Melita Orphanet J Rare Dis Position Statement BACKGROUND: Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, would improve understanding of the natural history of achondroplasia, quality of life, and related outcomes. METHODS: The Europe, Middle East, and Africa (EMEA) Achondroplasia Steering Committee comprises a multidisciplinary team of 17 clinical experts and 3 advocacy organization representatives. The committee undertook an exercise to identify essential data elements for a standardized prospective registry to study the natural history of achondroplasia and related outcomes. RESULTS: A range of RWE on achondroplasia is being collected at EMEA centres. Whereas commonalities exist, the data elements, methods used to collect and store them, and frequency of collection vary. The topics considered most important for collection were auxological measures, sleep studies, quality of life, and neurological manifestations. Data considered essential for a prospective registry were grouped into six categories: demographics; diagnosis and patient measurements; medical issues; investigations and surgical events; medications; and outcomes possibly associated with achondroplasia treatments. CONCLUSIONS: Long-term, high-quality data are needed for this rare, multifaceted condition. Establishing registries that collect predefined data elements across age spans will provide contemporaneous prospective and longitudinal information and will be useful to improve clinical decision-making and management. It should be feasible to collect a minimum dataset with the flexibility to include country-specific criteria and pool data across countries to examine clinical outcomes associated with achondroplasia and different therapeutic approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02755-w. BioMed Central 2023-06-26 /pmc/articles/PMC10294372/ /pubmed/37365619 http://dx.doi.org/10.1186/s13023-023-02755-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Position Statement
Alanay, Yasemin
Mohnike, Klaus
Nilsson, Ola
Alves, Inês
AlSayed, Moeenaldeen
Appelman-Dijkstra, Natasha M.
Baujat, Genevieve
Ben-Omran, Tawfeg
Breyer, Sandra
Cormier-Daire, Valerie
Gregersen, Pernille Axél
Guillén-Navarro, Encarna
Högler, Wolfgang
Maghnie, Mohamad
Mukherjee, Swati
Cohen, Shelda
Pimenta, Jeanne
Selicorni, Angelo
Semler, J. Oliver
Sigaudy, Sabine
Popkov, Dmitry
Sabir, Ian
Noval, Susana
Sessa, Marco
Irving, Melita
Real-world evidence in achondroplasia: considerations for a standardized data set
title Real-world evidence in achondroplasia: considerations for a standardized data set
title_full Real-world evidence in achondroplasia: considerations for a standardized data set
title_fullStr Real-world evidence in achondroplasia: considerations for a standardized data set
title_full_unstemmed Real-world evidence in achondroplasia: considerations for a standardized data set
title_short Real-world evidence in achondroplasia: considerations for a standardized data set
title_sort real-world evidence in achondroplasia: considerations for a standardized data set
topic Position Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294372/
https://www.ncbi.nlm.nih.gov/pubmed/37365619
http://dx.doi.org/10.1186/s13023-023-02755-w
work_keys_str_mv AT alanayyasemin realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT mohnikeklaus realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT nilssonola realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT alvesines realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT alsayedmoeenaldeen realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT appelmandijkstranatasham realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT baujatgenevieve realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT benomrantawfeg realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT breyersandra realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT cormierdairevalerie realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT gregersenpernilleaxel realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT guillennavarroencarna realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT hoglerwolfgang realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT maghniemohamad realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT mukherjeeswati realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT cohenshelda realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT pimentajeanne realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT selicorniangelo realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT semlerjoliver realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT sigaudysabine realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT popkovdmitry realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT sabirian realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT novalsusana realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT sessamarco realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset
AT irvingmelita realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset